Overexpression of Notch3 and pS6 Is Associated with Poor Prognosis in Human Ovarian Epithelial Cancer

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="7"><hr/></td></tr><tr class="thead"><td class="align_left">Variable</td><td class="align_center"><span style="width: 7.94191ptpx;"><svg height="8.68572pt" id="M82" style="vertical-align:-0.0498209pt" version="1.1" viewbox="-0.0498162 -8.6359 7.94191 8.68572" width="7.94191pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M578 512C578 619 494 650 387 650H140L134 622C219 615 223 609 210 542L127 119C112 40 104 34 23 28L17 0H235C317 0 387 7 444 33C515 65 564 122 564 195C564 289 495 335 412 352V354C505 373 578 422 578 512ZM486 510C486 422 423 367 314 367H257L294 565C299 591 305 602 315 608C324 614 339 617 362 617C421 617 486 595 486 510ZM466 200C466 100 393 35 296 35C222 35 198 51 212 127L250 333H303C388 333 466 303 466 200Z" id="g113-67"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="601" vert-adv-y="601"></glyph.data></g></svg></span></td><td class="align_center">SE</td><td class="align_center">Wald</td><td class="align_center"><span style="width: 7.83752ptpx;"><svg height="10.2124pt" id="M83" style="vertical-align:-3.42943pt" version="1.1" viewbox="-0.0498162 -6.78297 7.83752 10.2124" width="7.83752pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M570 304C570 398 525 448 414 448C385 448 343 445 312 434L329 511L321 518C297 504 262 482 244 460L233 411C195 397 159 381 128 358L135 332C160 347 189 360 224 373L111 -147C97 -210 84 -218 17 -231L13 -257L254 -247L259 -218L233 -216C183 -212 177 -202 189 -142L218 -1C238 -10 266 -12 283 -12C351 3 429 48 483 105C543 168 570 242 570 304ZM482 289C482 161 380 33 304 33C278 33 248 51 233 69L303 396C326 400 352 403 369 403C428 403 482 380 482 289Z" id="g113-113"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="593" vert-adv-y="593"></glyph.data></g></svg></span></td><td class="align_center">HR</td><td class="align_center">95% CI</td></tr><tr><td class="thead-hr" colspan="7"><hr/></td></tr><tr><td class="align_left">Clinical stages</td><td class="align_center">1.686</td><td class="align_center">0.787</td><td class="align_center">4.586</td><td class="align_center">0.032</td><td class="align_center">5.398</td><td class="align_center">1.154–25.259</td></tr><tr><td class="align_left">Notch3</td><td class="align_center">2.124</td><td class="align_center">0.692</td><td class="align_center">9.418</td><td class="align_center">0.002</td><td class="align_center">8.362</td><td class="align_center">2.154–32.461</td></tr><tr class="table-tr"><td colspan="7"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Multiple COX regression analysis of patients with ovarian epithelial cancer.

Mediators of Inflammation

tab5

Table 5

Table 5: Overexpression of Notch3 and pS6 Is Associated with Poor Prognosis in Human Ovarian Epithelial Cancer 